Pavol Tomašov

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry

Josef Veselka, Morten K. Jensen, Max Liebregts et al. · European Heart Journal · 2016 · 200 citations · Full text

Medicine, Anesthesiology, Cardiology +12

Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years

Josef Veselka, Pavol Tomašov, David Zemánek · Canadian Journal of Cardiology · 2011 · 49 citations

Medicine, Cardiology, Pharmacotherapy +9

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

Josef Veselka, David Zemánek, Pavol Tomašov et al. · Heart and Vessels · 2009 · 46 citations

Medicine, Cardiology, Internal Medicine +7

The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy

Jiří Bonaventura, Patricia Norambuena, Pavol Tomašov et al. · Archives of Medical Science · 2018 · 37 citations · Full text

Life Sciences, Cardiology, Genetics +16

Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies

Andreas Perrot, Pavol Tomašov, Eric Villard et al. · Archives of Medical Science · 2016 · 36 citations · Full text

Medicine, Cardiology, Genetics +11